Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart Lung, and Blood Institute (NHLBI): Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128:S213-S256. https://doi.org/10.1542/peds.2009-2107C.

Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U. Statins for children with familial hypercholesterolemia. Cochrane Database Syst Rev. 2019;2019:CD006401. https://doi.org/10.1002/14651858.CD006401.pub5.

Article  PubMed  PubMed Central  Google Scholar 

Cuchel M, Raal FJ, Hegele RA, Al-Rasadi K, Arca M, Averna M, Bruckert E, Freiberger T, Gaudet D, Harada-Shiba M, Hudgins LC, Kayikcioglu M, Masana L, Parhofer KG. Roeters van Lennep JE, Santos RD, Stroes ESG, Watts GF, Wiegman A, Stock JK, Tokgözoğlu LS, Catapano AL, Ray KK: 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance. Eur Heart J. 2023;44:2277–91. https://doi.org/10.1093/eurheartj/ehad197.

Article  PubMed  PubMed Central  Google Scholar 

McMahan CA, Gidding SS, Malcom GT, Tracy RE, Strong JP, McGill HCJ. Pathobiological Determinants of Atherosclerosis in Youth Research Group: Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis. Pediatrics. 2006;118:1447–55. https://doi.org/10.1542/peds.2006-0970.

Article  PubMed  Google Scholar 

Khoury M, McCrindle BW. The rationale, indications, safety, and use of statins in the pediatric population. Can J Cardiol. 2020;36:1372–83. https://doi.org/10.1016/j.cjca.2020.03.041.

Article  PubMed  Google Scholar 

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22. https://doi.org/10.1016/S0140-6736(02)09327-3.

Article  Google Scholar 

Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T. Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–8. https://doi.org/10.1001/jama.285.13.1711.

Article  CAS  PubMed  Google Scholar 

Ridker PM. Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation. 2002;105:2583–5. https://doi.org/10.1161/01.cir.0000017822.82512.62.

Article  PubMed  Google Scholar 

White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D, Colquhoun DM, Glasziou P, MacMahon S, Kirby AC, West MJ, Tonkin AM. Pravastatin therapy and the risk of stroke. N Engl J Med. 2000;343:317–26. https://doi.org/10.1056/NEJM200008033430502.

Article  CAS  PubMed  Google Scholar 

Ngamdu KS, Ghosalkar DS, Chung HE, Christensen JL, Lee C, Butler CA, Ho T, Chu A, Heath JR, Baig M, Wu W, Choudhary G, Morrison AR. Long-term statin therapy is associated with severe coronary artery calcification. PLoS ONE. 2023;18:e0289111. https://doi.org/10.1371/journal.pone.0289111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Rosendael AR, van den Hoogen IJ, Gianni U, Ma X, Tantawy SW, Bax AM, Lu Y, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Conte E, Marques H, de Araújo GP, Gottlieb I, Hadamitzky M, Leipsic JA, Maffei E, Pontone G, Shin S, Kim Y, Lee BK, Chun EJ, Sung JM, Lee S, Virmani R, Samady H, Sato Y, Stone PH, Berman DS, Narula J, Blankstein R, Min JK, Lin FY, Shaw LJ, Bax JJ, Chang H. Association of statin treatment with progression of coronary atherosclerotic plaque composition. JAMA Cardiol. 2021;6:1257–66. https://doi.org/10.1001/jamacardio.2021.3055.

Article  PubMed  Google Scholar 

Mendieta G, Pocock S, Mass V, Moreno A, Owen R, García-Lunar I, López-Melgar B, Fuster JJ, Andres V, Pérez-Herreras C, Bueno H, Fernández-Ortiz A, Sanchez-Gonzalez J, García-Alvarez A, Ibáñez B, Fuster V. Determinants of progression and regression of subclinical atherosclerosis over 6 years. J Am Coll Cardiol. 2023;82:2069–83. https://doi.org/10.1016/j.jacc.2023.09.814.

Article  CAS  PubMed  Google Scholar 

Almohtasib Y, Fancher AJ, Sawalha K. Emerging trends in atherosclerosis: time to address atherosclerosis from a younger age. Cureus. 2024;16:e56635. https://doi.org/10.7759/cureus.56635.

Article  PubMed  PubMed Central  Google Scholar 

Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, Watts GF, Borén J, Fazio S, Horton JD, Masana L, Nicholls SJ, Nordestgaard BG, van de Sluis B, Taskinen M, Tokgözoglu L, Landmesser U, Laufs U, Wiklund O, Stock JK, Chapman MJ, Catapano AL. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ibrahim S, Reeskamp LF, de Goeij JN, Hovingh GK, Planken RN, Bax WA, Min JK, Earls JP, Knaapen P, Wiegman A, Stroes ESG, Nurmohamed NS. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia. Eur J Prev Cardiol. 2024;31:892–900. https://doi.org/10.1093/eurjpc/zwae028.

Article  PubMed  Google Scholar 

Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML. American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Radiology and Intervention, and Council on Peripheral Vascular Disease: Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42:e48–60. https://doi.org/10.1161/ATV.0000000000000147.

Article  CAS  PubMed  Google Scholar 

Finneran P, Pampana A, Khetarpal SA, Trinder M, Patel AP, Paruchuri K, Aragam K, Peloso GM, Natarajan P. Lipoprotein(a) and coronary artery disease risk without a family history of heart disease. J Am Heart Assoc. 2021;10:e017470. https://doi.org/10.1161/JAHA.120.017470.

Article  PubMed  PubMed Central  Google Scholar 

Koschinsky ML, Bajaj A, Boffa MB, Dixon DL, Ferdinand KC, Gidding SS, Gill EA, Jacobson TA, Michos ED, Safarova MS, Soffer DE, Taub PR, Wilkinson MJ, Wilson DP, Ballantyne CM. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. J Clin Lipidol. 2024;18:e308–19. https://doi.org/10.1016/j.jacl.2024.03.001.

Article  PubMed  Google Scholar 

Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, Dweck MR, Koschinsky M, Lambert G, Mach F, McNeal CJ, Moriarty PM, Natarajan P, Nordestgaard BG, Parhofer KG, Virani SS, von Eckardstein A, Watts GF, Stock JK, Ray KK, Tokgözoğlu LS, Catapano AL. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022;43:3925–46. https://doi.org/10.1093/eurheartj/ehac361.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller ML, Mujkic A, Wright CC. Use of lipid lowering medications in youth. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext. South Dartmouth (MA): MDText.com, Inc; 2000. https://www.ncbi.nlm.nih.gov/books/NBK395575/. Accessed 15 Oct 2024.

McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr. 2003;143:74–80. https://doi.org/10.1016/S0022-3476(03)00186-0.

Article  CAS  PubMed  Google Scholar 

van der Graaf A, Nierman MC, Firth JC, Wolmarans KH, Marais AD, de Groot E. Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia. Acta Paediatr. 2006;95:1461–6. https://doi.org/10.1080/08035250600702602.

Article  PubMed  Google Scholar 

Clauss SB, Holmes KW, Hopkins P, Stein E, Cho M, Tate A, Johnson-Levonas AO, Kwiterovich PO. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics. 2005;116:682–8. https://doi.org/10.1542/peds.2004-2090.

Article  PubMed  Google Scholar 

Stein EA, Illingworth DR, Kwiterovich POJ, Liacouras CA, Siimes MA, Jacobson MS, Brewster TG, Hopkins P, Davidson M, Graham K, Arensman F, Knopp RH, DuJovne C, Williams CL, Isaacsohn JL, Jacobsen CA, Laskarzewski PM, Ames S, Gormley GJ. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA. 1999;281:137–44. https://doi.org/10.1001/jama.281.2.137.

Article  CAS  PubMed  Google Scholar 

Knipscheer HC, Boelen CC, Kastelein JJ, van Diermen DE, Groenemeijer BE, van den Ende A, Büller HR, Bakker HD. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr Res. 1996;39:867–71. https://doi.org/10.1203/00006450-199605000-00021.

Article  CAS  PubMed  Google Scholar 

Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJG, Kastelein JJP. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292:331–7. https://doi.org/10.1001/jama.292.3.331.

Article  CAS  PubMed  Google Scholar 

Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg ASP, van der Graaf A, de Groot E, Wijburg FA, Kastelein JJP, Hutten BA. Statin treatment in children with familial hypercholesterolemia: the younger, the better. Circulation. 2007;116:664–8.